Evidence map›Paper›PMID 34975821›Full record

ArticleFrontiers in microbiology2021

Characterization of

Kantapich Srikham, Wichittra Daengprok, Piyanuch Niamsup, Mongkol Thirabunyanon

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Anti-Inflammatory Efficacy of Human-DerivedJournal of microbiology and biotechnology · 2023
    Article
  17. Article
  18. Review
  19. Article
  20. A Combination of Two Probiotics,Microorganisms · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kantapich SrikhamProgram in Biotechnology, Faculty of Science, Maejo University, Chiang Mai, Thailand.
Wichittra DaengprokProgram in Food Science and Technology, Faculty of Engineering and Agro Industry, Maejo University, Chiang Mai, Thailand.
Piyanuch NiamsupProgram in Biotechnology, Faculty of Science, Maejo University, Chiang Mai, Thailand.
Mongkol ThirabunyanonProgram in Biotechnology, Faculty of Science, Maejo University, Chiang Mai, Thailand.
Maejo University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast milk is well known as the abundant source of beneficial bacteria. A new alternative source of human probiotic origin from breast milk is in demand and currently of interest for both the functional food industry and biopharmaceuticals. The aim in this study was to investigate the anticancer and antioxidant efficacies of the new potential probiotics isolated from human breast milk. Three strains of lactic acid bacteria (LAB) have shown their potential probiotic criteria including antimicrobial activity, non-hemolytic property, and survival in acid and bile salt conditions. These strains showed high abilities on cell surface hydrophobicity, auto-aggregation, and co-aggregation. The genera identification by 16S rRNA sequencing and comparison revealed that they were

Indexed as

anticancerantioxidantbreast milkcancerlactic acid bacteria (LAB)probiotics

Identifiers

PMID34975821
PMCPMC8714912
OpenAlexW4200138923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.